Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sinusitis | 9 | 2008 | 210 | 0.480 |
Why?
|
| Pneumococcal Infections | 6 | 2008 | 46 | 0.370 |
Why?
|
| Undaria | 1 | 2004 | 1 | 0.250 |
Why?
|
| Phytotherapy | 1 | 2004 | 133 | 0.230 |
Why?
|
| Plant Extracts | 1 | 2004 | 244 | 0.210 |
Why?
|
| Rhinitis | 3 | 2008 | 175 | 0.190 |
Why?
|
| Streptococcus pneumoniae | 5 | 2006 | 48 | 0.190 |
Why?
|
| Antiviral Agents | 1 | 2004 | 510 | 0.190 |
Why?
|
| Quinolines | 2 | 2006 | 95 | 0.130 |
Why?
|
| Nasal Mucosa | 2 | 2006 | 186 | 0.130 |
Why?
|
| Hypersensitivity | 2 | 2006 | 154 | 0.130 |
Why?
|
| Ovalbumin | 3 | 2006 | 109 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 2 | 2006 | 746 | 0.090 |
Why?
|
| Th1 Cells | 3 | 2006 | 164 | 0.090 |
Why?
|
| Kaposi Varicelliform Eruption | 1 | 2008 | 6 | 0.080 |
Why?
|
| Smallpox Vaccine | 1 | 2008 | 12 | 0.080 |
Why?
|
| Ciprofloxacin | 1 | 2008 | 29 | 0.080 |
Why?
|
| Paranasal Sinuses | 2 | 2006 | 60 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 89 | 0.080 |
Why?
|
| Th2 Cells | 2 | 2006 | 146 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2006 | 2232 | 0.070 |
Why?
|
| Respirovirus Infections | 1 | 2006 | 12 | 0.070 |
Why?
|
| Leukotriene Antagonists | 1 | 2006 | 25 | 0.070 |
Why?
|
| Acetates | 1 | 2006 | 66 | 0.070 |
Why?
|
| Aza Compounds | 1 | 2006 | 8 | 0.070 |
Why?
|
| Azithromycin | 1 | 2006 | 13 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2008 | 326 | 0.070 |
Why?
|
| Mupirocin | 1 | 2006 | 6 | 0.070 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2006 | 62 | 0.070 |
Why?
|
| Conjunctiva | 1 | 2006 | 19 | 0.070 |
Why?
|
| Gram-Positive Bacteria | 1 | 2006 | 18 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2008 | 3092 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2005 | 88 | 0.070 |
Why?
|
| Ascomycota | 1 | 2004 | 16 | 0.060 |
Why?
|
| Epistaxis | 1 | 2004 | 19 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 64 | 0.060 |
Why?
|
| Mycoses | 1 | 2004 | 46 | 0.060 |
Why?
|
| Herpesvirus 2, Human | 1 | 2004 | 45 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2004 | 143 | 0.060 |
Why?
|
| Acute Disease | 4 | 2006 | 826 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2006 | 1047 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2006 | 1195 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2004 | 182 | 0.050 |
Why?
|
| Mice | 8 | 2008 | 11352 | 0.050 |
Why?
|
| Pain | 1 | 2004 | 391 | 0.050 |
Why?
|
| Herpesvirus 1, Human | 1 | 2004 | 244 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2008 | 679 | 0.050 |
Why?
|
| Colony Count, Microbial | 2 | 2008 | 46 | 0.040 |
Why?
|
| Animals | 8 | 2008 | 26581 | 0.040 |
Why?
|
| CD8 Antigens | 2 | 2006 | 82 | 0.040 |
Why?
|
| CD4 Antigens | 2 | 2006 | 83 | 0.040 |
Why?
|
| CD11b Antigen | 2 | 2006 | 36 | 0.030 |
Why?
|
| Adoptive Transfer | 2 | 2005 | 168 | 0.030 |
Why?
|
| Female | 6 | 2008 | 44507 | 0.020 |
Why?
|
| Isoindoles | 1 | 2008 | 14 | 0.020 |
Why?
|
| Plasma | 1 | 2008 | 50 | 0.020 |
Why?
|
| Organophosphonates | 1 | 2008 | 50 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2008 | 95 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 154 | 0.020 |
Why?
|
| Family Health | 1 | 2008 | 162 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 66 | 0.020 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 52 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2008 | 78 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2008 | 265 | 0.020 |
Why?
|
| Cytosine | 1 | 2008 | 127 | 0.020 |
Why?
|
| Benzamides | 1 | 2008 | 229 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2008 | 172 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2006 | 25 | 0.020 |
Why?
|
| Nasal Lavage Fluid | 1 | 2006 | 26 | 0.020 |
Why?
|
| Sendai virus | 1 | 2006 | 8 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2008 | 293 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2006 | 66 | 0.020 |
Why?
|
| Nasal Provocation Tests | 1 | 2006 | 129 | 0.020 |
Why?
|
| Sulfides | 1 | 2006 | 68 | 0.020 |
Why?
|
| Histamine | 1 | 2006 | 126 | 0.020 |
Why?
|
| Fluoroquinolones | 1 | 2006 | 22 | 0.020 |
Why?
|
| Ointments | 1 | 2006 | 12 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 2006 | 91 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 456 | 0.020 |
Why?
|
| Genes, RAG-1 | 1 | 2005 | 13 | 0.020 |
Why?
|
| Cataract Extraction | 1 | 2006 | 31 | 0.020 |
Why?
|
| Glycolipids | 1 | 2005 | 29 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2006 | 39 | 0.020 |
Why?
|
| Vitrectomy | 1 | 2006 | 52 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2005 | 135 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 894 | 0.020 |
Why?
|
| Allergens | 1 | 2006 | 179 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 370 | 0.020 |
Why?
|
| Humans | 4 | 2008 | 86601 | 0.020 |
Why?
|
| Male | 4 | 2008 | 40956 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2006 | 394 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 425 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2005 | 559 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 1823 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 3611 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 920 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2005 | 1924 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2005 | 724 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 4210 | 0.010 |
Why?
|
| Middle Aged | 2 | 2006 | 25017 | 0.010 |
Why?
|
| United States | 1 | 2008 | 6665 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6501 | 0.010 |
Why?
|
| Aged | 1 | 2006 | 18402 | 0.010 |
Why?
|
| Adult | 1 | 2006 | 25640 | 0.000 |
Why?
|